Edwards Lifesciences (NYSE:EW) Given New $90.00 Price Target at Truist Financial

Edwards Lifesciences (NYSE:EW) Given New $90.00 Price Target at Truist Financial

Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Truist Financial from $87.00 to $90.00 in a research report released on Monday morning,Benzinga reports. The firm currently has a hold rating on the medical research company’s stock. EW has been the topic of several other reports. Stifel Nicolaus lifted their target price on shares of Edwards Lifesciences from $85.00 to $95.00 and gave the stock a “buy” rating in a resea…